Thursday, September 23, 2021

India says COVID-19 Biological E vaccine 90% effective

Must read

- Advertisement -

The Head of India’s COVID-19 vaccine panel, N. K. Arora, revealed that the Biological E vaccine is expected to have 90 per cent effectiveness against the virus.

READ ALSO:   JUST IN: NDLEA intercepts over N2bn illicit drugs at Lagos airport, arrests 2 suspects

Doctor Arora who disclosed this in an interview with a local television news channel NDTV said the vaccine was entering Phase 3 trials and could be available by October.

According to the doctor, the made-in-India vaccine would likely be a game changer in the fight against the pandemic.

According to Arora, Biological E’s vaccine to be called Corbevax is similar to the Novavax vaccine.

India started the vaccination against COVID-19 on January 16, by administrating two made-in-India vaccines namely Covishield and Covaxin.

READ ALSO:   Labour rejects Nigerian govt’s plans to slash salaries

Recently, Russian COVID-19 vaccine Sputnik V too was rolled out in the country.

Xinhua/NAN

READ ALSO:   COVID-19: Nigeria’s unemployment may rise by 30% — Expert
- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here
READ ALSO:   Labour rejects Nigerian govt’s plans to slash salaries

- Advertisement -

Latest article

- Advertisement -
cosgrove